Proposed Data Collection Submitted for Public Comment and Recommendations, 12360-12361 [2017-04045]

Download as PDF 12360 Federal Register / Vol. 82, No. 40 / Thursday, March 2, 2017 / Notices level and any faculty changes. Sponsors who elect to have their approval renewed for an additional 5 year period submit a renewal application and supporting documentation for review by NIOSH staff to ensure the course curriculum meets all current standard requirements. Approved courses that elect to offer NIOSH-Approved Spirometry Refresher Courses must submit a separate application and supporting documents for review by NIOSH staff. Institutions and organizations throughout the country voluntarily submit applications and materials to become course sponsors and carry out training. Submissions are required for NIOSH to evaluate a course and determine whether it meets the criteria in the Standard and whether technicians will be adequately trained as mandated under the Standard. NIOSH will disseminate a one-time customer satisfaction survey to course directors and sponsor representatives to evaluate our service to courses, the effectiveness of the program changes implemented since 2005, and the usefulness of potential Program enhancements. The annualized figures slightly overestimate the actual burden, due to rounding of the number of respondents for even allocation over the three-year clearance period. The estimated annual burden to respondents is 159 hours. There will be no cost to respondents. ESTIMATED ANNUALIZED BURDEN HOURS Average burden per response (in hours) Number of responses per respondent Number of respondents Total burden (in hours) Type of respondents Form name Potential Sponsors ............................ Initial Application .............................. Annual Report .................................. Report for course changes .............. Renewal Application ......................... Refresher Course Application .......... One-time Customer Satisfaction ...... Survey .............................................. 3 30 24 13 3 32 1 1 1 1 1 1 8 30/60 30/60 6 8 12/60 24 15 12 78 24 6 Total ........................................... ........................................................... ........................ ........................ ........................ 159 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017–04047 Filed 3–1–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–17–17RT; Docket No. CDC–2017– 0013] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:13 Mar 01, 2017 Jkt 241001 collection project titled ‘‘Factors Influencing the Transmission of Influenza.’’ This data collection project will help examine the amount of influenza virus in airborne particles produced by subjects with influenza and it relationship to biomarkers in the blood. DATES: Written comments must be received on or before May 1, 2017. ADDRESSES: You may submit comments, identified by Docket No. CDC–2017– 0013 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS– D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. To request more information on the proposed project or to obtain a copy of FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the E:\FR\FM\02MRN1.SGM 02MRN1 12361 Federal Register / Vol. 82, No. 40 / Thursday, March 2, 2017 / Notices burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Proposed Project Factors Influencing the Transmission of Influenza—New—National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Institute for Occupational Safety and Health influenza virus, and the levels of influenza infection-associated biomarkers will be measured in blood samples from these subjects. Volunteer adult participants will be recruited by a test coordinator using a poster and flyers describing the study. Interested potential participants will be screened verbally to verify that they have influenza-like symptoms and that they do not have any medical conditions that would preclude their participation. Qualified participants who agree to participate in the study will be asked to read and sign an informed consent form, and then to complete a short health questionnaire. After completing the forms, the participant’s oral temperature will be measured and two nasopharyngeal swabs and five milliliters of blood will be collected. The participant then will be asked to cough repeatedly into an aerosol particle collection system, and the airborne particles produced by the participant during coughing will be collected and tested. The study will require 40 volunteer test subjects each year for three years, for a total of 120 test participants. NIOSH intends to seek a three-year OMB approval to conduct this information collection. There are no costs to respondents other than their time. (NIOSH) is authorized to conduct research to advance the health and safety of workers under Section 20(a)(1) of the 1970 Occupational Safety and Health Act. Influenza continues to be a major public health concern because of the substantial health burden from seasonal influenza and the potential for a severe pandemic. Although influenza is known to be transmitted by infectious secretions, these secretions can be transferred from person to person in many different ways, and the relative importance of the different pathways is not known. The likelihood of the transmission of influenza virus by small infectious airborne particles produced during coughing and breathing is particularly unclear. The question of airborne transmission is especially important in healthcare facilities, where influenza patients tend to congregate during influenza season, because it directly impacts the infection control and personal protective measures that should be taken by healthcare workers. The purpose of this study is to gain a better understanding of the production of infectious aerosols by patients with influenza, and to compare this to the levels of biomarkers of influenza infection in the blood of these patients. To do this, airborne particles produced by volunteer subjects with influenza will be collected and tested for ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents Potential participant Qualified participant Qualified participant Qualified participant Number of respondents Form name Average burden per response (in hrs.) Number of responses per respondent Total burden (in hrs.) .......................... .......................... .......................... .......................... Initial Verbal Screening .................... Informed consent form ..................... Health questionnaire ........................ Medical Testing ................................ 240 120 120 120 1 1 1 1 3/60 15/60 5/60 40/60 12 30 10 80 Total ........................................... ........................................................... ........................ ........................ ........................ 132 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2017–04045 Filed 3–1–17; 8:45 am] [30Day–17–16AJE] sradovich on DSK3GMQ082PROD with NOTICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for VerDate Sep<11>2014 16:13 Mar 01, 2017 Jkt 241001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of E:\FR\FM\02MRN1.SGM 02MRN1

Agencies

[Federal Register Volume 82, Number 40 (Thursday, March 2, 2017)]
[Notices]
[Pages 12360-12361]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04045]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-17-17RT; Docket No. CDC-2017-0013]

Proposed Data Collection Submitted for Public Comment and
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``Factors Influencing the
Transmission of Influenza.'' This data collection project will help
examine the amount of influenza virus in airborne particles produced by
subjects with influenza and it relationship to biomarkers in the blood.

DATES: Written comments must be received on or before May 1, 2017.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0013 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.

Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the

[[Page 12361]]

burden of the collection of information on respondents, including
through the use of automated collection techniques or other forms of
information technology; and (e) estimates of capital or start-up costs
and costs of operation, maintenance, and purchase of services to
provide information. Burden means the total time, effort, or financial
resources expended by persons to generate, maintain, retain, disclose
or provide information to or for a Federal agency. This includes the
time needed to review instructions; to develop, acquire, install and
utilize technology and systems for the purpose of collecting,
validating and verifying information, processing and maintaining
information, and disclosing and providing information; to train
personnel and to be able to respond to a collection of information, to
search data sources, to complete and review the collection of
information; and to transmit or otherwise disclose the information.

Proposed Project

Factors Influencing the Transmission of Influenza--New--National
Institute for Occupational Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).

Background and Brief Description

The National Institute for Occupational Safety and Health (NIOSH)
is authorized to conduct research to advance the health and safety of
workers under Section 20(a)(1) of the 1970 Occupational Safety and
Health Act.
Influenza continues to be a major public health concern because of
the substantial health burden from seasonal influenza and the potential
for a severe pandemic. Although influenza is known to be transmitted by
infectious secretions, these secretions can be transferred from person
to person in many different ways, and the relative importance of the
different pathways is not known. The likelihood of the transmission of
influenza virus by small infectious airborne particles produced during
coughing and breathing is particularly unclear. The question of
airborne transmission is especially important in healthcare facilities,
where influenza patients tend to congregate during influenza season,
because it directly impacts the infection control and personal
protective measures that should be taken by healthcare workers.
The purpose of this study is to gain a better understanding of the
production of infectious aerosols by patients with influenza, and to
compare this to the levels of biomarkers of influenza infection in the
blood of these patients. To do this, airborne particles produced by
volunteer subjects with influenza will be collected and tested for
influenza virus, and the levels of influenza infection-associated
biomarkers will be measured in blood samples from these subjects.
Volunteer adult participants will be recruited by a test
coordinator using a poster and flyers describing the study. Interested
potential participants will be screened verbally to verify that they
have influenza-like symptoms and that they do not have any medical
conditions that would preclude their participation. Qualified
participants who agree to participate in the study will be asked to
read and sign an informed consent form, and then to complete a short
health questionnaire. After completing the forms, the participant's
oral temperature will be measured and two nasopharyngeal swabs and five
milliliters of blood will be collected. The participant then will be
asked to cough repeatedly into an aerosol particle collection system,
and the airborne particles produced by the participant during coughing
will be collected and tested.
The study will require 40 volunteer test subjects each year for
three years, for a total of 120 test participants. NIOSH intends to
seek a three-year OMB approval to conduct this information collection.
There are no costs to respondents other than their time.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hrs.)
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Potential participant......... Initial Verbal 240 1 3/60 12
Screening.
Qualified participant......... Informed consent 120 1 15/60 30
form.
Qualified participant......... Health 120 1 5/60 10
questionnaire.
Qualified participant......... Medical Testing. 120 1 40/60 80
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 132
----------------------------------------------------------------------------------------------------------------

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-04045 Filed 3-1-17; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.